The Effect of Physiotherapy on Chronic Low Back Pain

Kayseri City Hospital

Status: Completed

Conditions: Chronic Low-back Pain

Treatments: Drug: Nsaid; Other: Phsiotheraphy

Study type: Interventional

Funder types: Other

Identifiers

NCT06234891

Kayseri City Hospital

Details and patient eligibility

About

Demographic data of patients diagnosed with chronic low back pain and planned for medical treatment (n:30) and physical therapy in addition to medical treatment (n:30), as well as before and after treatment; Visual analog scale (VAS), Oswestry Disability Index (ODI) and Short form 36 (SF-36) quality of life scoring, Lumbar range of motion (LHA), straight leg raising test (DBK) and hand-finger ground distance (EPZM) were evaluated. Hot pack, transcutaneous electrical nerve stimulation (TENS) and ultrasound were given as physical therapy agents.

Full description

Patients with VAS, ODI and SF-36 quality of life values before treatment, in addition to demographic data, who have applied to our Physical Medicine and Rehabilitation Policlinic in our hospital with chronic low back pain in the last 3 (three) months, are determined, and at least 30 above the age of 18 who received physiotherapy and who did not receive physiotherapy.

patient consents obtained and VAS, ODI and SF-36 quality of life values questioned.

Pre- and post-treatment values compared, and intragroup changes compared in both groups and evaluated whether physiotherapy contributes to pain, functionality and quality of life in treatment.

Enrollment: 60 patients

Sex: All

Ages: 20 to 79 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients who have been prescribed medical treatment or physiotherapy for mechanical back pain
• Those with demographic information as well as VAS, ODI information in their files
• Patients between the ages of 20-79 who applied to our hospital with the complaint of chronic low back pain

Exclusion criteria

• Non-mechanical back pain
• Patients with physiotherapy contraindications
• Those with inflammatory diseases
• Severe heart failure
• Stroke, spinal cord injury, plegia due to traumatic brain injury
• A history of malignancy
• Active infection during treatment
• Having metal implants in the waist area
• Established osteoporosis
• Those with pacemakers

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

Group 1

Active Comparator group

Description:

NSAID

Treatment:

Drug: Nsaid

Group 2

Active Comparator group

Description:

nsaid and physiotherapy

Treatment:

Other: Phsiotheraphy

Drug: Nsaid